help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanti, J. F.
Right arrow Articles by Le Marchand- Brustel, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanti, J. F.
Right arrow Articles by Le Marchand- Brustel, Y.

Endocrinology, Vol 131, 2319-2324, Copyright © 1992 by Endocrine Society

ARTICLES

Potential involvement of the carboxy-terminus of the Glut 1 transporter in glucose transport

JF Tanti, N Gautier, M Cormont, V Baron, E Van Obberghen and Y Le Marchand- Brustel
INSERM U-145, Faculte de Medecine, Nice, France.

The role of the carboxy-terminal domain of the Glut 1 glucose transporter was investigated using an antipeptide antibody to the C- terminal part of the molecule. The study was performed in fibroblasts transfected with the cDNA coding for the human insulin receptor. These cells acutely respond to insulin for glucose transport. Using antipeptide antibodies to Glut 1 and Glut 4, we first established that these cells expressed only Glut 1. Then, to define the role of the C- terminal part of Glut 1 in glucose transport, the antibodies were loaded into the cells by electroporation. When anti-Glut 1 immunoglobulins were introduced into the cells, a 60% increase in basal deoxyglucose and 3-O-methylglucose transport was observed compared to that in cells electroporated with nonimmune immunoglobulins. The stimulatory action of the antipeptide was not due to an increase in the total amount of transporters. It was found only at low glucose concentrations, suggesting that the affinity of the transporter, rather than its maximal capacity, was changed. Finally, the effect of antibody was additive to that of insulin. The interaction between the anti-Glut 1 antibody and the carboxy-tail of the transporter seems to lead to an increase in the intrinsic activity of the transporter, suggesting that this part of the molecule could be implicated in the regulation of glucose uptake.


This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
R. C. Bunn, M. A. Jensen, and B. C. Reed
Protein Interactions with the Glucose Transporter Binding Protein That Provide a Link between GLUT1 and the Cytoskeleton
Mol. Biol. Cell, April 1, 1999; 10(4): 819 - 832.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
A. E. Buchs, S. Sasson, H. G. Joost, and E. Cerasi
Characterization of GLUT5 Domains Responsible for Fructose Transport
Endocrinology, March 1, 1998; 139(3): 827 - 831.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society